Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines

International Journal of Cancer

Volumn 71, Issue 5, 1997, Pages 724-731

  Mantovani, Giovanni ^a   MacCiò, Antonio ^a   Pisano, Mario ^b   Versace, Renato ^b   Lai, Paola ^a   Esu, Silvia ^a   Massa, Elena ^a   Ghiani, Massimo ^a   Dessì, Daniela ^a   Melis, Gian Benedetto ^a   Del Giacco, G Sergio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Binaghi Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADULT; AGED; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EFFUSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ASCITIC FLUID; CELL CYCLE; CELL DIVISION; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2; LUNG NEOPLASMS; LYMPHOCYTES; MIDDLE AGED; MONOCYTES; NEOPLASMS; PHYTOHEMAGGLUTININS; PLEURAL EFFUSION; RECOMBINANT PROTEINS;

EID: 0031008765     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970529)71:5<724::AID-IJC6>3.0.CO;2-T     Document Type: Article

References (32)

1. BARTON, D.P.J., BLANCHARD, D.K., MICHELINI-NORRIS, B., NICOSIA, S.V., CAVANAGH, D. and DJEU, J.Y., High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer. Blood, 81, 424-429 (1993).
2. BEREK, J.S., CHUNG, C., KALDI, K., WATSON, J.M., KNOX, R.M. and MARTINEZ-MAZA, O., Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Amer. J. Obstet. Gynecol., 164, 1038-1044 (1991).
3. CHEN, Y.M., YANG, W.K., WHANG-PENG, J., KUO, B.I. and PERNG, R.P., Elevation of interleukin-10 in malignant pleural effusions. Chest, 110, 433-436 (1996).
4. DIAMANTSTEIN, T., Interleukin-2 and the interleukin-2 receptor complex. In: R.C. Rees (ed.), Biology and clinical application of IL2, pp. 15-22, Oxford University Press, Oxford (1990).
5. DINARELLO, C.A., Interleukin-1 and its biologically related cytokines. Adv. Immunol., 44, 153-295 (1989).
6. GELIN, J., MOLDAWER, L.L., LONNROTH, C., SHERRY, B., CHIZZONITE, R. and LUNDHOLM, K., Role of endogenous tumor necrosis factor α and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res., 51, 415-421 (1991).
7. GORELIK, E. and HERBERMAN, R.B., Immunological control of tumor metastases. In: H. Kaiser (ed.), Fundamental aspects of cancer: cancer growth and progression, pp. 134-143, Kluwer, Dordrecht (1989).
8. GUZMAN, J., HILGARTH, M., BROSS, K.J., WIEHLE, U., ROSS, A., KRESIN, V. and COSTABEL, U., Lymphocyte subpopulations in malignant ascites of serous papillary ovarian adenocarcinoma. Acta Cytol. 32, 811-815 (1988).
9. HIRTE, H.W., CLARK, D.A., O'CONNELL, G., RUSTHOVEN, J. and MAZURKA, J., Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-beta in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody. Cell Immunol., 142, 207-216 (1992).
10. INTERNATIONAL UNION AGAINST CANCER, TNM classification of malignant tumours, P. Hermanek and L.H. Sobin (eds.), 4th ed., 2nd rev., Springer, Berlin (1992).
11. IOANNIDES, C.G., FISK, B., TOMASOVICH, B., PANDITA, R., AGGARWAL, B.B. and FREEDMAN, R.S., Induction of interleukin 2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes. Cancer Immunol. Immunother., 35, 83-91 (1992).
12. KATANO, M., NAGUMO, F., KUBOTA, E., YAMAMOTO, H., MATSUO, T., HISATSUGU, T. and TADANO, J., Autologous tumor-specific cytotoxic T-cell clone established from tumor-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2 (rIL2): activation by autologous tumor cell alone. Biotherapy. 6, 25-32 (1993).
13. LACKI, J., MARKOWSKA, J. and WIKTOROVICZ, K., Phenotype of lymphocytes in ovarian tumor peritoneal fluid. A preliminary study. Europ. J. Gynaecol. Oncol., 13, 475-479 (1992).
14. LAI, P., RABINOWICH, H., KROWLEY-NOWICK, P.A., BELL, M.C., MANTOVANI, G. and WHITESIDE, T.L., Alterations in expression and function of signal transducing proteins in tumor-associated T and NK cells in patients with ovarian carcinoma. Clin. Cancer Res., 2, 161-173 (1996).
15. LAZENBY, A.W., ROTH, J.A., OWEN-SCHAUB, B. and GRIMM, E.A., IL-1 synergy with IL-2 in the generation of lymphokine-activated killer cells is mediated by TNF-alpha and beta (lymphotoxin). Cytokine, 4, 479-487 (1992).
16. LENTZ, S.S., MCKEAN, D.J., KOVACH, J.S. and PODRATZ, K.C., Phenotypic and functional characteristics of mononuclear cells in ovarian carcinoma tumors. Gynecol Oncol. 34, 136-140 (1989).
17. LI, B.Y., MOHANRAJ, D., OLSON, M.C., MORADI, M., TWIGGS, L., CARSON, L.F. and RAMAKRISHNAN, S., Human ovarian epithelial cancer cells cultured in vitro express both interleukin 1α and β genes. Cancer Res., 52, 2248-2252 (1992).
18. MANTOVANI, G. and 12 OTHERS, Membrane bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies. Cell Biophys., 22, 79-99 (1993).
19. MANTOVANI, G., MACCIÒ, A., BIANCHI, A., CURRELI, L., GHIANI, M., SANTONA., M.C. and DEL GIACCO, G.S., Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. Inf. J. clin. Lab. Res., 25, 135-141 (1995a).
20. MANTOVANI, G., MACCIÒ, A., ESU, S., LAI, P., GHIANI, M., TURNU, E., CONTU, G., VOLPE, A. and DEL GIACCO, G.S., Lack of correlation between defective cell-mediated immunity and levels of secreted or circulating cytokines in a study of 90 cancer patients. Inf. J. Oncol., 5, 1211-1217 (1994).
21. MANTOVANI, G., MACCIÒ, A., VERSACE, R., PISANO, M., LAI, P., ESU, S., GHIANI, M., DESSÌ, D., TURNU, E., SANTONA, M.C., CHERCHI, R. and DEL GIACCO, G.S., Tumor associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC. J. mol. Med., 73, 409-416 (1995b).
22. MCNAMARA, M.J., ALEXANDER, H.R. and NORTON, J.A., Cytokines and their role in the pathophysiology of cancer cachexia. J. Parent. Enter: Nutr., 16, 50S-55S (1992).
23. MELIOLI, G. and 12 OTHERS. Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2). Int. J. Cancer, 43, 231-234 (1989).
24. MELIOLI, G., FERRARI, I., CASARTELLI, G. and RAGNI, N., Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes. Gynecol. Oncol., 48, 301-307 (1993).
25. RICEVUTI, G., MAZZONE, A., PASOTTI, D. and NOTARIO, A., The cytokine network: their role in physiopathology and therapeutic implications. Int. J. Immunopathol. Pharmacol., 5, 67-76 (1992).
26. ROSENBERG, S.A. and 12 OTHERS, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med., 316, 889-897 (1987).
27. SATO, T., INOUE, G., TAKAO, Y., CLARK, C., MEDLEY, W., BLOOME, E., MASTRANGELO, M.J. and BERD, D., Elevated serum IL-10 in metastatic melanoma. Proc. Amer. Soc. clin. Oncol., 15, 274 (1996).
28. SMITH, K.A., Interleukin-2: inception, impact and implications. Science, 240, 1169-1174 (1988).
29. STRASSMAN, G., FONG, M., KENNEY, J.S. and JACOB, C.O., Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J. clin. Invest., 89, 1681-1684 (1992).
30. STRASSMAN, G. and KAMBAYASHI, T., Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine receptor therapy. Cytokines mol. Ther., 1, 107-115 (1995).
31. WATSON, J.M., SENSINTAFFAR, J.L., BEREK, J. and MARTINEZ-MAZA, O., Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res., 50, 6959-6965 (1990).
32. WU, S., RODABAUGH, K., MARTINEZ-MAZA, O., WATSON, J.M., SILBERSTEIN, D.S., BOYER, C.M., PETERS, W.P., WEINBERG, J.B., BEREK, J.S. and BAST, R.C., JR., Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-6 and tumor necrosis factor-α. Amer. J. Obstet. Gynecol., 166, 997-1007 (1992).